Q2 2025 · 13F-HR/A
Exome Asset Management LLCholdings as filed
Filed 2025-08-15 · accession 0001420506-25-002212
$134.5M
Reported value
63
Positions
2025-06-30
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 464287954 | — | ISHARES TR | $7.4M | 5.47% | 200,000 | Common | SOLE |
| 10806X102 | BBIO | BRIDGEBIO PHARMA INC | $6.7M | 4.99% | 155,533 | Common | SOLE |
| 40131M109 | GH | GUARDANT HEALTH INC | $5.1M | 3.80% | 98,182 | Common | SOLE |
| 374163103 | GERN | GERON CORP | $4.8M | 3.58% | 3,414,377 | Common | SOLE |
| 462222100 | IONS | IONIS PHARMACEUTICALS INC | $4.8M | 3.56% | 121,116 | Common | SOLE |
| 88033G407 | THC | TENET HEALTHCARE CORP | $4.8M | 3.53% | 27,000 | Common | SOLE |
| 046353108 | AZNN | ASTRAZENECA PLC | $3.9M | 2.92% | 28,362 | PUT | SOLE |
| 19240Q201 | COGT | COGENT BIOSCIENCES INC | $3.8M | 2.85% | 533,647 | Common | SOLE |
| 23282W605 | CYTK | CYTOKINETICS INC | $3.8M | 2.85% | 115,817 | Common | SOLE |
| 76029N106 | REPL | REPLIMUNE GROUP INC | $3.7M | 2.75% | 397,846 | Common | SOLE |
| 532457108 | LLY | ELI LILLY & CO | $3.6M | 2.71% | 4,673 | Common | SOLE |
| 834203309 | SLNO | SOLENO THERAPEUTICS INC | $3.5M | 2.59% | 41,641 | Common | SOLE |
| 46120E602 | ISRG | INTUITIVE SURGICAL INC | $3.5M | 2.57% | 6,358 | Common | SOLE |
| 254604101 | IRON | DISC MEDICINE INC | $3.2M | 2.42% | 61,356 | Common | SOLE |
| 632307104 | NTRA | NATERA INC | $3.2M | 2.34% | 18,650 | Common | SOLE |
| 00973Y108 | AKRO | AKERO THERAPEUTICS INC | $3.1M | 2.32% | 58,579 | PUT | SOLE |
| 359616109 | FULC | FULCRUM THERAPEUTICS INC | $3.1M | 2.28% | 444,949 | Common | SOLE |
| 80706P103 | SRRK | SCHOLAR ROCK HLDG CORP | $3.0M | 2.22% | 84,339 | Common | SOLE |
| 87164F105 | SNDX | SYNDAX PHARMACEUTICALS INC | $2.9M | 2.15% | 308,298 | Common | SOLE |
| 92337C203 | VSTM | VERASTEM INC | $2.5M | 1.85% | 599,900 | Common | SOLE |
| 74006W207 | PRAX | PRAXIS PRECISION MEDICINES I | $2.5M | 1.84% | 59,002 | Common | SOLE |
| 70975L107 | PEN | PENUMBRA INC | $2.3M | 1.72% | 9,000 | Common | SOLE |
| 282559103 | ETNBGBP | 89BIO INC | $2.3M | 1.70% | 233,426 | Common | SOLE |
| 89422G107 | TVTX | TRAVERE THERAPEUTICS INC | $2.3M | 1.69% | 153,278 | Common | SOLE |
| 152309100 | CNTA | CENTESSA PHARMACEUTICALS PLC | $2.2M | 1.63% | 166,944 | Common | SOLE |
| 004225108 | ACAD | ACADIA PHARMACEUTICALS INC | $2.0M | 1.50% | 93,222 | CALL | SOLE |
| 640268906 | — | NEKTAR THERAPEUTICS | $1.9M | 1.44% | 75,000 | Common | SOLE |
| 946784105 | WAY | WAYSTAR HLDG CORP | $1.9M | 1.43% | 46,900 | Common | SOLE |
| 21833P301 | CRBP | CORBUS PHARMACEUTICALS HLDGS | $1.9M | 1.42% | 277,317 | Common | SOLE |
| 88025U109 | TXG | 10X GENOMICS INC | $1.9M | 1.41% | 163,658 | Common | SOLE |
| 26818M108 | DYN | DYNE THERAPEUTICS INC | $1.9M | 1.39% | 195,933 | Common | SOLE |
| 75901B107 | RGNX | REGENXBIO INC | $1.9M | 1.38% | 226,060 | Common | SOLE |
| 913903100 | UHS | UNIVERSAL HLTH SVCS INC | $1.8M | 1.36% | 10,100 | Common | SOLE |
| 92337R101 | VERA | VERA THERAPEUTICS INC | $1.8M | 1.34% | 76,700 | Common | SOLE |
| 22663K107 | CRNX | CRINETICS PHARMACEUTICALS IN | $1.8M | 1.34% | 62,700 | Common | SOLE |
| 03073E105 | COR | CENCORA INC | $1.8M | 1.34% | 6,000 | CALL | SOLE |
| 03753U106 | APLSUSD | APELLIS PHARMACEUTICALS INC | $1.7M | 1.27% | 98,600 | Common | SOLE |
| 28036F105 | EWTX | EDGEWISE THERAPEUTICS INC | $1.6M | 1.21% | 124,470 | Common | SOLE |
| 89422G907 | — | TRAVERE THERAPEUTICS INC | $1.6M | 1.21% | 110,000 | Common | SOLE |
| 09058V103 | BCRX | BIOCRYST PHARMACEUTICALS INC | $1.5M | 1.15% | 172,883 | Common | SOLE |
| 48576UAA4 | — | KARYOPHARM THERAPEUTICS INC | $1.5M | 1.13% | 2,000,000 | Common | SOLE |
| 15117B202 | CLDX | CELLDEX THERAPEUTICS INC NEW | $1.5M | 1.10% | 73,000 | Common | SOLE |
| 803607AD2 | SRPT 1.25 09/15/27 | SAREPTA THERAPEUTICS INC | $1.4M | 1.07% | 2,000,000 | Common | SOLE |
| 90400D908 | — | ULTRAGENYX PHARMACEUTICAL IN | $1.4M | 1.01% | 37,500 | CALL | SOLE |
| 38341P102 | GOSS | GOSSAMER BIO INC | $1.4M | 1.00% | 1,097,999 | Common | SOLE |
| 86366E106 | GPCR | STRUCTURE THERAPEUTICS INC | $1.1M | 0.83% | 53,744 | Common | SOLE |
| 52490G102 | LEGN | LEGEND BIOTECH CORP | $1.0M | 0.77% | 29,100 | Common | SOLE |
| 55287L101 | MBX | MBX BIOSCIENCES INC | $719,697 | 0.54% | 63,076 | Common | SOLE |
| L01800108 | ALVO | ALVOTECH | $714,753 | 0.53% | 78,372 | Common | SOLE |
| N62509109 | NAMS | NEWAMSTERDAM PHARMA COMPANY | $662,355 | 0.49% | 36,574 | Common | SOLE |
| 20451W101 | CMPS | COMPASS PATHWAYS PLC | $597,923 | 0.44% | 213,544 | Common | SOLE |
| G31249108 | ESTA | ESTABLISHMENT LABS HLDGS INC | $559,501 | 0.42% | 13,100 | Common | SOLE |
| 91324P102 | UNH | UNITEDHEALTH GROUP INC | $436,758 | 0.32% | 1,400 | CALL | SOLE |
| 02155H950 | — | ALTIMMUNE INC | $414,090 | 0.31% | 107,000 | PUT | SOLE |
| 92941V308 | VYNE | VYNE THERAPEUTICS INC | $344,801 | 0.26% | 208,970 | Common | SOLE |
| 45783C200 | TIL | INSTIL BIO INC | $337,446 | 0.25% | 16,200 | Common | SOLE |
| 032724106 | ANAB | ANAPTYSBIO INC | $333,000 | 0.25% | 15,000 | Common | SOLE |
| 28617K101 | ELDN | ELEDON PHARMACEUTICALS INC | $309,333 | 0.23% | 114,145 | Common | SOLE |
| 53635D202 | LQDA | LIQUIDIA CORPORATION | $255,430 | 0.19% | 20,500 | Common | SOLE |
| 03879J100 | ABUS | ARBUTUS BIOPHARMA CORP | $233,246 | 0.17% | 75,484 | Common | SOLE |
| 359616909 | — | FULCRUM THERAPEUTICS INC | $137,600 | 0.10% | 20,000 | CALL | SOLE |
| 28623U101 | — | ELEVATION ONCOLOGY INC | $40,511 | 0.03% | 110,353 | Common | SOLE |
| 589492957 | — | MEREO BIOPHARMA GROUP PLC | $39,566 | 0.03% | 14,600 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.